New approach aims to control cancer while preserving quality of life
NCT ID NCT07213570
Summary
This study is testing whether a drug called regorafenib can help control advanced colorectal cancer that has spread and returned after initial treatment. Researchers want to see if this less intensive approach can slow cancer growth while maintaining patients' quality of life better than standard second-line treatments. The trial will enroll 60 patients with specific genetic markers who responded well to their first treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Nazionale Tumori | "Fondazione Pascale"
RECRUITINGNaples, Italy, Italy
Conditions
Explore the condition pages connected to this study.